Back to GetFilings.com



Table of Contents

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 10-Q

 


 

(MARK ONE)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For The Quarterly Period Ended June 30, 2004

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1934

 

For The Transition Period From              To             

 

Commission File No. 000-28715

 


 

NEOFORMA, INC.

(Exact name of the Registrant as Specified in its Charter)

 


 

Delaware   77-0424252

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

3061 Zanker Rd., San Jose, CA   95134
(Address of principal executive offices)   (Zip code)

 

(408) 468-4000

(The Registrant’s telephone number, including area code)

 


 

Securities registered pursuant to Section 12(b) of the Act:

 

None

 

Securities registered pursuant to Section 12(g) of the Act:

 

Common Stock, $0.001 Par Value Per Share

 


 

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes  x    No  ¨

 

The number of shares of the Registrant’s common stock outstanding on August 2, 2004 was 20,073,295.

 



Table of Contents

TABLE OF CONTENTS

 

          Page

PART I. FINANCIAL INFORMATION

   3

ITEM 1.

   Unaudited Condensed Consolidated Financial Statements:     
     Unaudited Condensed Consolidated Balance Sheets as of June 30, 2004 and December 31, 2003    3
     Unaudited Condensed Consolidated Statements of Operations for the Three and Six Months Ended June 30, 2004 and 2003    4
     Unaudited Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2004 and 2003    5
     Notes to Unaudited Condensed Consolidated Financial Statements    6

ITEM 2.

   Management’s Discussion and Analysis of Financial Condition and Results of Operations    12

ITEM 3.

   Quantitative and Qualitative Disclosures About Market Risk    30

ITEM 4.

   Controls and Procedures    30

PART II. OTHER INFORMATION

   31

ITEM 1.

   Legal Proceedings    31

ITEM 2.

   Changes in Securities, Use of Proceeds and Issuer Purchases of Equity Securities    31

ITEM 3.

   Defaults Upon Senior Securities    31

ITEM 4.

   Submission of Matters to a Vote of Security Holders    31

ITEM 5.

   Other Information    32

ITEM 6.

   Exhibits and Reports on Form 8-K    32

SIGNATURE

   33

EXHIBITS

    


Table of Contents

PART I. FINANCIAL INFORMATION

 

Item 1. Unaudited Condensed Consolidated Financial Statements

 

NEOFORMA, INC.

 

CONDENSED CONSOLIDATED BALANCE SHEETS

 

(in thousands, except per share amounts)

 

(unaudited)

 

     December 31, 2003*

    June 30, 2004

 
Assets                 

Current assets:

                

Cash and cash equivalents

   $ 13,481     $ 20,375  

Short-term investments

     3,138       2,138  

Accounts receivable, net of reserves of $235 and $322 as of December 31, 2003 and June 30, 2004, respectively

     3,776       3,533  

Related party accounts receivable

     456       —    

Prepaid expenses and other current assets

     2,775       2,583  
    


 


Total current assets

     23,626       28,629  

Property and equipment, net

     7,432       9,890  

Intangibles, net

     2,022       1,728  

Goodwill

     1,652       1,652  

Capitalized partnership costs, net

     106,003       75,070  

Non-marketable investments

     83       83  

Restricted cash

     1,020       1,020  

Other assets

     1,376       885  
    


 


Total assets

   $ 143,214     $ 118,957  
    


 


Liabilities and Stockholders’ Equity                 

Current liabilities:

                

Accounts payable

   $ 2,727     $ 1,533  

Accrued payroll

     4,199       3,848  

Other accrued liabilities

     3,183       2,734  

Deferred revenue

     2,651       1,922  
    


 


Total current liabilities

     12,760       10,037  

Deferred rent

     657       621  

Deferred revenue, less current portion

     554       468  
    


 


Total liabilities

     13,971       11,126  
    


 


Stockholders’ equity:

                

Preferred stock, $0.001 par value per share:

                

Authorized—5,000 shares, no shares issued and outstanding at December 31, 2003 and June 30, 2004, respectively

     —         —    

Common stock, $0.001 par value per share:

                

Authorized—300,000 shares at December 31, 2003 and June 30, 2004, respectively

                

Issued and outstanding: 18,943 and 19,915 shares at December 31, 2003 and June 30, 2004, respectively

     19       20  

Additional paid-in capital

     827,570       837,288  

Notes receivable from stockholders

     (5,422 )     (203 )

Deferred compensation

     (218 )     (4,940 )

Unrealized gain on available for sale securities

     1       1  

Accumulated deficit

     (692,707 )     (724,335 )
    


 


Total stockholders’ equity

     129,243       107,831  
    


 


Total liabilities and stockholders’ equity

   $ 143,214     $ 118,957  
    


 



* Derived from audited financial statements.

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3


Table of Contents

NEOFORMA, INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

 

(in thousands, except per share amounts)

 

(unaudited)

 

     Three Months Ended
June 30,


   

Six Months Ended

June 30,


 
     2003

    2004

    2003

    2004

 

Revenue:

                                

Related party revenue, net (see Note 3)

   $ —       $ —       $ 539     $ —    

Non-related party revenue

     2,519       3,340       4,582       6,268  
    


 


 


 


Total revenue

     2,519       3,340       5,121       6,268  

Operating expenses:

                                

Cost of services

     1,481       2,682       2,859       4,743  

Operations

     4,799       2,811       9,941       5,809  

Product development

     4,183       4,403       8,926       8,041  

Selling and marketing

     4,633       3,513       9,610       7,169  

General and administrative

     3,130       2,468       6,097       4,706  

Amortization of intangibles

     147       147       294       294  

Amortization of partnership costs (see Note 3)

     833       1,669       833       3,141  

Write-off of stockholder notes receivable

     —         4,115       —         4,115  
    


 


 


 


Total operating expenses

     19,206       21,808       38,560       38,018  
    


 


 


 


Loss from operations

     (16,687 )     (18,468 )     (33,439 )     (31,750 )

Other income/(expense):

                                

Interest income

     80       55       131       124  

Interest expense

     (300 )     (2 )     (574 )     (3 )

Other income/(expense)

     (41 )     1       (117 )     1  
    


 


 


 


Net loss

   $ (16,948 )   $ (18,414 )   $ (33,999 )   $ (31,628 )
    


 


 


 


Net loss per share:

                                

Basic and diluted

   $ (0.94 )   $ (0.95 )   $ (1.91 )   $ (1.65 )
    


 


 


 


Weighted average shares—basic and diluted

     17,985       19,357       17,763       19,213  
    


 


 


 


 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4


Table of Contents

NEOFORMA, INC.

 

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

 

(in thousands)

 

(unaudited)

 

    

Six Months Ended

June 30,


 
     2003

    2004

 

Cash flows from operating activities:

                

Net loss

   $ (33,999 )   $ (31,628 )

Adjustments to reconcile net loss to net cash used in operating activities:

                

Restricted common stock issued to employees

     10       —    

Provision for doubtful accounts

     141       110  

Accrued interest receivable on notes receivable from stockholders

     (32 )     (11 )

Depreciation and amortization of property and equipment

     7,061       2,483  

Amortization of intangibles

     294       294  

Amortization of partnership costs classified as an operating expense (see Note 3)

     833       3,141  

Amortization of deferred compensation

     1,717       1,666  

Write-off of stockholder notes receivable

     —         4,115  

Change in assets and liabilities:

                

Accounts receivable

     (1,698 )     589  

Prepaid expenses and other current assets

     378       192  

Other assets

     357       491  

Accounts payable

     (1,734 )     (1,194 )

Other accrued liabilities and accrued payroll

     (4,159 )     (797 )

Deferred revenue

     1,039       (815 )

Deferred rent

     21       (36 )

Accrued interest on related party notes payable

     (2,271 )     —    
    


 


Net cash used in operating activities

     (32,042 )     (21,400 )
    


 


Cash flows from investing activities:

                

Purchases of marketable investments

     (2,082 )     (2,890 )

Proceeds from the sale or maturity of marketable investments

     2,005       3,890  

Capitalization of software development costs

     —         (3,236 )

Purchases of property and equipment

     (3,679 )     (1,652 )
    


 


Net cash used in investing activities

     (3,756 )     (3,888 )
    


 


Cash flows from financing activities:

                

Amortization of partnership costs offset against related party revenue (see Note 3)

     34,531       30,937  

Repayments of notes payable

     (3,399 )